THE POLYMORPHIC OXIDATION OF BETA-ADRENOCEPTOR ANTAGONISTS - CLINICAL PHARMACOKINETIC CONSIDERATIONS

被引：82

作者：

LENNARD, MS

TUCKER, GT

WOODS, HF

机构：

来源：

CLINICAL PHARMACOKINETICS | 1986年 / 11卷 / 01期

关键词：

D O I：

10.2165/00003088-198611010-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1 / 17

页数：17

共 93 条

[1]

ALVAN G, 1982, LANCET, V1, P333

[2] METABOLISM OF METOPROLOL IN RAT INVITRO AND INVIVO [J].

ARFWIDSSON, A ;

BORG, KO ;

HOFFMANN, KJ ;

SKANBERG, I .

XENOBIOTICA, 1976, 6 (11) :691-711

[3]

BAI SA, 1983, J PHARMACOL EXP THER, V224, P62

[4]

BAI TR, 1982, J ROY COLL PHYS LOND, V16, P239

[5] INFLUENCE OF RENAL-FAILURE ON THE HEPATIC-CLEARANCE OF BUFURALOL IN MAN [J].

BALANT, L ;

FRANCIS, RJ ;

TOZER, TN ;

MARMY, A ;

TSCHOPP, JM ;

FABRE, J .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (05) :421-438

[6]

BALANT L, 1976, SCHWEIZ MED WSCHR, V106, P1403

[7] INHIBITION OF ANTIPYRINE METABOLISM BY BETA-ADRENOCEPTOR ANTAGONISTS [J].

BAX, NDS ;

LENNARD, MS ;

TUCKER, GT .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (06) :779-784

[8] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE [J].

BERTILSSON, L ;

DENGLER, HJ ;

EICHELBAUM, M ;

SCHULZ, HU .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) :153-155

[9]

BOOBIS AR, 1983, MOL PHARMACOL, V23, P474

[10] GENETIC-POLYMORPHISM IN DRUG OXIDATION - INVITRO STUDIES OF HUMAN DEBRISOQUINE 4-HYDROXYLASE AND BUFURALOL 1'-HYDROXYLASE ACTIVITIES [J].

BOOBIS, AR ;

MURRAY, S ;

HAMPDEN, CE ;

DAVIES, DS .

BIOCHEMICAL PHARMACOLOGY, 1985, 34 (01) :65-71

← 1 2 3 4 5 6 7 8 9 10 →